Usefulness of aortic valve calcium scores by electron beam computed tomography as a marker for aortic stenosis

American Journal of Cardiology

Volumn 92, Issue 3, 2003, Pages 349-353

  Shavelle, David M ^b   Budoff, Matthew J ^b   Buljubasic, Nediljka ^b   Wu, Audrey H ^b   Takasu, Junichiro ^b   Rosales, Joseph ^b   Otto, Catherine M ^b   Zhao, Xue Qiao ^b   O'Brien, Kevin D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM;

ADULT; AGED; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ECHOCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0042848480     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00646-5     Document Type: Article

References (20)

1. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M. Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 15:1990;827-832.
2. Callister T.Q., Raggi P., Cooil B., Lippolis N.J., Russo D.J. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. (see comments) N Engl J Med. 339:1998;1972-1978.
3. Callister T.Q., Cooil B., Raya S.P., Lippolis N.J., Russo D.J., Raggi P. Coronary artery disease improved reproducibility of calcium scoring with an electron-beam CT volumetric method . Radiology. 208:1998;807-814.
4. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 25:1989;358-367.
5. Shavelle D.M., Takasu J., Budoff M.J., Mao S., O'Brien K.D. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet. 359:2002;1125-1126.
6. Budoff M.J., Mao S., Takasu J., Shavelle D.M., Zhao X.Q., O'Brien K.D. Reproducibility of electron-beam CT measures of aortic valve calcification. Acad Radiol. 9:2002;1122-1127.
7. Kizer J.R., Gefter W.B., deLemos A.S., Scoll B.J., Wolfe M.L., Mohler E.R. III. Electron beam computed tomography for the quantification of aortic valvular calcification. J Heart Valve Dis. 10:2001;361-366.
8. Pohle K., Maffert R., Ropers D., Moshage W., Stilianikis N., Daniel W.G., Achenbach S. Progression of aortic valve calcification association with coronary atherosclerosis and cardiovascular risk factors . Circulation. 104:2001;1927-1932.
9. Otto C.M., Pearlman A.S. Doppler echocardiography in adults with symptomatic aortic stenosis. Diagnostic utility and cost-effectiveness. Arch Intern Med. 148:1988;2553-2560.
10. Pellikka P.A., Nishimura R.A., Bailey K.R., Tajik A.J. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol. 15:1990;1012-1017.
11. Otto C.M., Burwash I.G., Legget M.E., Munt B.I., Fujioka M., Healy N.L., Kraft C.D., Miyake-Hull C.Y., Schwaegler R.G. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 95:1997;2262-2270.
12. Rosenhek R., Binder T., Porenta G., Lang I., Christ G., Schemper M., Maurer G., Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 343:2000;611-617.
13. Palta S., Pai A.M., Gill K.S., Pai R.G. New insights into the progression of aortic stenosis implications for secondary prevention . Circulation. 101:2000;2497-2502.
14. Carabello B.A. Clinical practice. Aortic stenosis. N Engl J Med. 346:2002;677-682.
15. Kaden J.J., Freyer S., Weisser G., Willingstorfer W., Bilbal A., Pfleger S., Suselbeck T., Haase K.K., Dempfle C.E., Borggrefe M. Correlation of degree of aortic valve stenosis by Doppler echocardiogram to quantity of calcium in the valve by electron beam tomography. Am J Cardiol. 90:2002;554-557.
16. Achenbach S., Ropers D., Mohlenkamp S., Schmermund A., Muschiol G., Groth J., Kusus M., Regenfus M., Daniel W.G., Erbel R., Moshage W. Variability of repeated coronary artery calcium measurements by electron beam tomography. Am J Cardiol. 87:2001;A210-A213.
17. Budoff M.J., Lane K.L., Bakhsheshi H., et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol. 86:2000;8-11.
18. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 98:1998;839-844.
19. Albert M.A., Danielson E., Rifai N., Ridker P.M. Effect of statin therapy on C-reactive protein levels the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study . JAMA. 286:2001;64-70.
20. O'Brien K.D., Reichenbach D.D., Marcovina S.M., Kuusisto J., Alpers C.E., Otto C.M. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 16:1996;523-532.